XML 42 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Other Income (Expense), Net
 12 Months Ended
Dec. 31, 2017
Other Income and Expenses [Abstract]  
Other Income, Net [Text Block]
Other Income (Expense), Net
 
2017
 
2016
 
2015
Government grants and incentives
$
7

 
$
8

 
$
3

Foreign exchange loss
(3
)
 
(3
)
 
(20
)
Gain on derecognition of noncontrolling interest


 


 
5

Strategic transaction expenses
(25
)
 
(13
)
 
(4
)
Insurance and other recoveries


 
10

 
4

Gain on sale of marketable securities


 
7

 
1

Amounts attributable to previously divested/closed operations
3

 


 
1

Other, net
9

 
9

 
11

Other income (expense), net
$
(9
)
 
$
18

 
$
1



Foreign exchange gains and losses on cross-currency intercompany loan balances that are not of a long-term investment nature are included above. Foreign exchange gains and losses on intercompany loans that are permanently invested are reported in OCI. During 2015, foreign exchange losses were primarily driven by the impact the strengthening U.S. dollar had on our Mexican peso and euro forward contracts.

Upon completion of the divestiture of our operations in Venezuela in January 2015, we recognized a gain on the derecognition of the noncontrolling interest in a former Venezuelan subsidiary.

Strategic transaction expenses relate primarily to costs incurred in connection with acquisition and divestiture related activities, including costs to complete the transaction and post-closing integration costs. Strategic transaction expenses in 2017 are primarily attributable to our acquisitions of USM - Warren, BFP and BPT. Strategic transaction expenses in 2016 are primarily attributable to our acquisition of SJT Forjaria Ltda. and our divestitures of DCLLC and Nippon Reinz. See Notes 2 and 3 for additional information.

Amounts attributable to previously divested/closed operations includes the receipt of the remaining proceeds on our December 2016 divestiture of DCLLC during the second quarter of 2017. See Note 3 for additional information. During 2016, DCLLC received $8 as recovery of costs previously incurred on behalf of other participants in a consortium that existed to administer certain legacy personal injury claims, and they sold investments which generated $7 of gain.

During 2015, we reached a settlement with an insurance carrier for the recovery of previously incurred legal costs.